Home
Conditions
Cholangiocarcinoma

Clinical trial condition

Cholangiocarcinoma

Explore clinical trials studying Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.

490 public trials 154 recruiting studies

Refine in advanced search Browse all conditions

Cholangiocarcinoma trial results

Recruiting

Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, BTC or NEN

NCT06735560

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +16 more
Locations: CHU de Nantes Nantes, France

AP-HP - Site de Beaujon Paris, France

View Trial Details

Recruiting

Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic Cholangiocarcinoma

NCT06058663

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +8 more
Locations: Mayo Clinic in Florida Jacksonville, Florida, United States

View Trial Details

Recruiting

A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement

NCT06728410

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +6 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Recruiting

Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic Cholangiocarcinoma

NCT07570849

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
Locations: 180 Fenglin Road Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Phase II Study of the Combination of Durvalumab (MEDI4736) (PDL1 Inhibitor) and Olaparib (PARP Inhibitor) in Advanced Cholangiocarcinoma After Initial Chemotherapy and Durvalumab (BIL-PPP)

NCT06441747

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +3 more
Locations: Chris O'Brien Lifehouse Camperdown, New South Wales, Australia

Monash Medical Centre Clayton, New South Wales, Australia

Royal North Shore Hospital St Leonards, New South Wales, Australia

Westmead Hospital Westmead, New South Wales, Australia

View Trial Details

Recruiting

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

NCT07030140

Conditions: Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +13 more
Locations: Shandong Cancer Hospital and Institute Jinan, Shandong, China

View Trial Details

Recruiting

FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers

NCT07478523

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
Locations: CHU de Bordeaux Pessac, France

View Trial Details

Recruiting

In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary Cancers

NCT07206355

Conditions: Adenocarcinoma, Biliary Tract Cancer (BTC), Biliary Tract Cancer (CCA), +19 more
Locations: University of Nottingham Nottingham, United Kingdom

View Trial Details

Recruiting

A Study of MGC028 in Participants With Advanced Solid Tumors

NCT06723236

Conditions: Adenocarcinoma, Advanced Solid Tumors, Carcinoma, +21 more
Locations: UCSF - Helen Diller Family Cancer Center San Francisco, California, United States

Mass General Brigham Boston, Massachusetts, United States

Dana Farber/Harvard Cancer Center Boston, Massachusetts, United States

South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States

View Trial Details

Recruiting

Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio

NCT05655949

Conditions: Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +14 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Cholangiocarcinoma

Cholangiocarcinoma trial results

Related conditions